Skip to content
Link Pharma Chem logo

Link Pharma Chem

524748 BSE
Price unavailable

Link Pharma Chem (LINKPH) share price was ₹24.25 at the 28 Oct 2026 close; market capitalisation ₹10.80 Cr; P/E (TTM) 2425.00; sector Chemicals. The share price fell 30.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 12.3% year on year to ₹8.77 Cr and net profit was ₹0.32 Cr, against ₹0.40 Cr a year earlier (compared with Jun 2025). Promoters held 52.40% of Link Pharma Chem in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 46/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹24.25 −11.49 −32.15% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹10.80 Cr
P/E (TTM)
2,425
EBITDA
₹1.60 Cr
Return on Equity
0.6%
Debt to Equity
0.57
Book Value
₹28.80
EPS (TTM)
₹0.01
52W High
₹35.89
52W Low
₹21.00

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Commodities › Chemicals › Commodity Chemicals

SRF
₹2,350.0032.2269,660 Cr4.550.21%13.07%14.64%17,997 Cr2,162 Cr
Tata Chemicals
₹604.60—15,403 Cr0.731.84%-7.73%-2.69%15,521 Cr-1,971 Cr
Deepak Fertilisers & Petrochemicals
₹1,178.1015.1114,872 Cr2.170.84%9.90%11.30%12,189 Cr984 Cr
Gujarat Narmada Valley Fert & Chem
₹515.207.307,570 Cr0.834.12%8.75%10.38%8,860 Cr1,037 Cr
Tanfac Industries
—103.797,489 Cr10.360.13%18.80%25.38%725 Cr68 Cr
Gujarat Alkalies & Chemicals
₹552.7561.144,060 Cr0.783.20%-0.05%1.29%4,622 Cr66 Cr
GHCL
₹387.407.713,569 Cr1.003.04%13.30%16.87%3,138 Cr473 Cr
Link Pharma Chem (this company)
—2,425.0011 Cr0.840.00%0.60%4.85%29 Cr0 Cr
Median 8 companies₹578.6832.227,529 Cr0.921.34%9.33%10.84%6,741 Cr271 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

46 Average
Overall score

Data confidence 98/100

Category scores

Quality Good 55
Returns, margins, earnings quality 22% weight
Valuation Weak 37
Cheap vs sector & own history 24% weight
Growth Good 57
Sales & profit trajectory 9% weight
Financial Health Poor 27
Solvency, leverage, coverage 9% weight
Momentum Poor 35
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.91 times its book value

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.65% over past five years.
  • Company has a low return on equity of -5.93% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
7.81% higher than 3Y

change over 1 year

Net Income Growth
-110% lower than 3Y

change over 1 year

Cash Flow Change
-20.07%

change over 1 year

EBITDA Margin Change
384%

change over 1 year Operating margin 5.13% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
7.88
6.05
7.94
8.03
8.85
4.8
5.34
6.45
7.81
6.29
6.73
6.59
8.77
Expenses
8.84
6.93
7.66
7.12
8.3
5.1
5.23
6.68
7.17
5.95
6.04
6.83
8.32
Operating Profit
-0.96
-0.88
0.28
0.91
0.55
-0.3
0.11
-0.23
0.64
0.34
0.69
-0.24
0.45
OPM %
-12.18%
-14.55%
3.53%
11.33%
6.21%
-6.25%
2.06%
-3.57%
8.19%
5.41%
10.25%
-3.64%
5.13%
Other Income
0.31
-0.03
0.37
-0.01
0.27
0.36
-0.56
0.12
0.21
0.05
-0.2
0.15
0.35
Interest
0.23
0.22
0.23
0.19
0.22
0.21
0.21
0.14
0.1
0.13
0.14
0.15
0.14
Depreciation
0.26
0.26
0.27
0.25
0.24
0.24
0.24
0.24
0.24
0.25
0.25
0.25
0.27
PBT
-1.14
-1.39
0.15
0.46
0.36
-0.39
-0.9
-0.49
0.51
0.01
0.1
-0.49
0.39
Tax %
-28.07%
-26.62%
-46.67%
45.65%
16.67%
-20.51%
-24.44%
-26.53%
21.57%
0%
40%
-16.33%
17.95%
Net Profit
-0.82
-1.02
0.22
0.26
0.3
-0.31
-0.67
-0.35
0.4
0.02
0.07
-0.41
0.32
EPS (₹)
-1.85
-2.3
0.5
0.59
0.68
-0.7
-1.51
-0.79
0.9
0.05
0.16
-0.92
0.72
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17.58
12.35
16.1
23.53
24.5
25.47
34.81
53.56
38.76
29.9
25.43
27.43
28.38
Expenses
18.36
12.16
13.56
20.75
22.48
22.05
31.67
50.02
36.04
30.55
25.3
25.98
27.14
Operating Profit
-0.78
0.19
2.54
2.78
2.02
3.42
3.14
3.54
2.72
-0.65
0.13
1.45
1.24
OPM %
-4.44%
1.54%
15.78%
11.81%
8.24%
13.43%
9.02%
6.61%
7.02%
-2.17%
0.51%
5.29%
4.37%
Other Income
0.21
2.39
-0.43
0.07
0.19
-0.69
-0.15
0.46
-0.15
0.64
0.19
0.2
0.35
Interest
1.44
0.91
0.8
0.62
0.39
0.36
0.44
0.45
0.76
0.87
0.78
0.53
0.56
Depreciation
1.13
0.93
0.83
0.86
0.89
0.93
0.87
0.93
0.92
1.03
0.94
0.98
1.02
PBT
-3.14
0.74
0.48
1.37
0.93
1.44
1.68
2.62
0.89
-1.91
-1.4
0.14
0.01
Tax %
-29.94%
20.27%
54.17%
17.52%
29.03%
34.03%
35.12%
28.24%
26.97%
-28.8%
-26.43%
42.86%
—
Net Profit
-2.2
0.59
0.23
1.13
0.66
0.95
1.08
1.88
0.65
-1.36
-1.03
0.08
0
EPS (₹)
-4.95
1.33
0.52
2.54
1.49
2.14
2.43
4.23
1.46
-3.06
-2.32
0.18
0.01
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.44
4.44
4.44
4.44
4.44
4.44
4.44
4.44
4.44
4.44
4.44
4.44
Reserves
3.93
4.52
4.16
5.35
5.94
6.99
8.12
10.03
10.6
9.27
8.22
8.35
Borrowings
10.8
5.41
4.73
2.71
2.64
3.56
3.66
6.39
8.76
9.22
5.78
7.31
Other Liabilities
7.35
3.46
3.81
4.69
4.99
3.98
9.82
8.1
8.66
3.02
4.86
4.87
Total Liabilities
26.52
17.83
17.14
17.19
18.01
18.97
26.04
28.96
32.46
25.95
23.3
24.97
Fixed Assets
17.51
10.13
9.57
9.76
9.14
8.81
8.71
8.79
9
9.94
9.28
10.38
CWIP
0
0
0
0.01
0.43
0
0
0.21
0
0
0
0
Investments
0.02
0.02
0.03
0.03
0.03
0.03
0.03
4.52
3.64
2.93
2.06
2.47
Other Assets
8.99
7.68
7.54
7.39
8.41
10.13
17.3
15.44
19.82
13.08
11.96
12.12
Total Assets
26.52
17.83
17.14
17.19
18.01
18.97
26.04
28.96
32.46
25.95
23.3
24.97
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5.13
-3.91
2.23
3.79
1.36
2.95
4.84
-1.26
-1.71
-0.03
2.69
2.15
Investing
-3.27
8.72
-0.73
-1.15
-0.96
-1.66
-2.16
-4.97
-0.08
0.41
1.53
-2.66
Financing
-0.87
-5.75
-1.48
-2.63
-0.46
0.55
-0.33
2.27
1.61
-0.41
-4.21
0.99
Net Cash Flow
0.99
-0.94
0.02
0
-0.05
1.85
2.35
-3.95
-0.17
-0.03
0
0.48
Free Cash Flow
1.84
4.8
1.37
2.63
0.49
1.27
3.13
-2.01
-2.6
-0.86
2.43
0.05
CFO/OP
-658
-2,005
92
147
77
83
169
-17
-48
-52
2,046
150
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
63.74
68.86
49.42
49.33
45.29
71.51
58.19
36.6
34.18
62.87
72.05
70.26
Inventory Days
125
277
286
96.96
92.54
60.04
51.35
47.68
209
136
167
170
Days Payable
94.59
81.61
203
124
109
111
141
45.37
113
38.51
101
111
Cash Conversion Cycle
94.49
265
132
22.05
28.85
20.68
-31.16
38.9
131
160
138
130
Working Capital Days
-46.92
-6.8
0.23
31.64
31.43
51.45
10.49
14.17
26.74
5.13
15.07
-7.05
ROCE %
-8.74%
-3.64%
13%
15.41%
10.34%
18.71%
14.61%
13.16%
6.72%
-4.79%
-3%
3.48%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Link Pharma Chem insights

62 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

DIIs0.02%Promot.52.40%Others11.15%Public36.43%As ofSep 2026

Documents

Frequently Asked Questions about Link Pharma Chem

What does Link Pharma Chem Ltd do?
Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate[1]
Where is Link Pharma Chem Ltd (LINKPH) listed?
Link Pharma Chem Ltd trades under code 524748 on the BSE.
Which sector does Link Pharma Chem Ltd belong to?
Link Pharma Chem Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Link Pharma Chem Ltd?
Link Pharma Chem Ltd has a market capitalisation of ₹10.8 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Link Pharma Chem Ltd?
Link Pharma Chem Ltd trades at a PE ratio of 2425.00 as of 28 Oct 2026, on earnings per share of ₹0.01, against a book value of ₹28.8 per share.
What is the 52-week high and low of Link Pharma Chem Ltd?
Over the last 52 weeks Link Pharma Chem Ltd has traded between ₹21 and ₹35.89 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Link Pharma Chem Ltd?
Link Pharma Chem Ltd reported a return on equity of 0.60%. Its debt-to-equity ratio is 0.57.

Company Information

Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate[1]

Website linkpharmachem.co.in
Face Value ₹ 10
Shares Outstanding 44,54,865

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524748.md for Link Pharma Chem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month